Bacille Calmette-Guerin

BIOLOGICAL2 trials

Sponsors

Urological Oncology Council of Northern Tokyo, Bandim Health Project

Conditions

Bacille Calmette-GuérinBladder CancerInnate Immunity

Phase 3

Study of the Efficacy of Maintenance Therapy Using Uracil-tegafur (UFT) or Bacille Calmette-Guerin (BCG) for the Prevention of Recurrences of Superficial Bladder Cancer (EMBARK Study)

Urological Oncology Council of Northern TokyoBladder Cancer

Start: 2010-01-31End: 2019-12-31Target: 288Updated: 2011-03-24

Phase 4

Testing if BCG (Bacille Calmette-Guérin) Vaccination Can Induce Innate Immune Training in Adult People Above 50 Years of Age in Guinea-Bissau

CompletedNCT02953327

Bandim Health ProjectBacille Calmette-Guérin, Innate Immunity

Start: 2017-02-01End: 2020-06-15Updated: 2021-04-26

Related Papers

Bacillus Calmette-Guérin vaccination induces a trained innate immunity phenotype in adults over 50 years of age: A randomized trial in Guinea-Bissau.

2024-10-1713 citations